This Program Project grant application was prepared in response PA-01-075 """"""""Integrated Preclinical/Clinical Program for HIV Topical Microbicides"""""""". The broad, longterm goals of the proposed studies in this program project grant application are to develop a combination topical microbicide containing a non-nucleoside reverse transcriptase inhibitor. This multi-disciplinary team of investigators proposes to combine UC781, a particularly tight-binding NNRTI with other active agents to create a topical microbicide formulation having activity against several target sites. The Program Project grant is led by Dr. Sharon Hillier at the University of Pittsburgh/Magee-Womens Hospital. In Project 1, Dr. Michael Parniak proposes to conduct in vitro testing of UC781 with other active antiviral components to evaluate whether selection of drug-resistant HIV isolates will occur when a microbicide containing an NNRTI is applied topically. In Project 2, Dr. Phalguni Gupta will test anti-HIV activity and toxicity in a tissue explant model utilizing cervical tissues. In Project 3, Drs. Lisa Rohan and Charles Isaacs will seek to develop combinations of other active agents and excipients to be used with UC781. In Project 4, Dr. Daniel Landers proposes early clinical testing to evaluate the safety and toxicity of UC781, its pharmacokinetics, and transport into the upper genital tract. The Program Project grant is supported by an Administrative and Microbiology Core, both of which are directed by Dr. Sharon Hillier. In addition, this Program Project grant features close collaboration with Biosyn Inc., the company which has licensed UC781 as a topical microbicide and the formation of a Scientific Steering Committee comprised by key personnel from this grant and Biosyn scientists, who will collaborate on the proposed studies. This is a highly interactive and iterative set of studies which are designed to generate new knowledge on model development, selection of HIV resistance and development of innovative formulations which will be broadly applicable in the field of microbicides. In addition, there are studies which are complementary to the traditional drug development pathway for a topical microbicide.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI051661-03
Application #
6799641
Study Section
Special Emphasis Panel (ZAI1-VSG-A (J1))
Program Officer
Turpin, Jim A
Project Start
2002-09-30
Project End
2007-07-31
Budget Start
2004-08-01
Budget End
2005-07-31
Support Year
3
Fiscal Year
2004
Total Cost
$1,649,637
Indirect Cost
Name
Magee-Women's Research Institute and Foundation
Department
Type
DUNS #
119132785
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Bunge, Katherine E; Dezzutti, Charlene S; Rohan, Lisa C et al. (2016) A Phase 1 Trial to Assess the Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics of a Novel Dapivirine Vaginal Film. J Acquir Immune Defic Syndr 71:498-505
Yang, Haitao; Parniak, Michael A; Hillier, Sharon L et al. (2012) A thermodynamic study of the cyclodextrin-UC781 inclusion complex using a HPLC method. J Incl Phenom Macrocycl Chem 72:459-465
Bunge, Katherine; Macio, Ingrid; Meyn, Leslie et al. (2012) The safety, persistence, and acceptability of an antiretroviral microbicide candidate UC781. J Acquir Immune Defic Syndr 60:337-43
Austin, Michele N; Rabe, Lorna K; Hillier, Sharon L (2009) Limitations of the dye-based method for determining vaginal applicator use in microbicide trials. Sex Transm Dis 36:368-71
Patton, Dorothy L; Sweeney, Yvonne T Cosgrove; Paul, Kathleen J (2009) A summary of preclinical topical microbicide rectal safety and efficacy evaluations in a pigtailed macaque model. Sex Transm Dis 36:350-6
Ding, Ming; Tarwater, Patrick; Rodriguez, Milka et al. (2009) Estimation of the predictive role of plasma viral load on CD4 decline in HIV-1 subtype C-infected subjects in India. J Acquir Immune Defic Syndr 50:119-25
Sassi, Alexandra B; Isaacs, Charles E; Moncla, Bernard J et al. (2008) Effects of physiological fluids on physical-chemical characteristics and activity of topical vaginal microbicide products. J Pharm Sci 97:3123-39
Deslouches, Berthony; Gonzalez, Ivan A; DeAlmeida, Dilhari et al. (2007) De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia. J Antimicrob Chemother 60:669-72
Deslouches, Berthony; Islam, Kazi; Craigo, Jodi K et al. (2005) Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications. Antimicrob Agents Chemother 49:3208-16